Literature DB >> 21959600

Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty.

Kevin E Chan1, Timothy A Pflederer, David J R Steele, Michael P Lilly, T Alp Ikizler, Frank W Maddux, Raymond M Hakim.   

Abstract

BACKGROUND AND OBJECTIVES: Referring hemodialysis patients for elective access angiography and percutaneous transluminal angioplasty (PTA) is commonly done to prevent access failure, yet the effectiveness of this procedure remains unclear. DESIGN, SETTING, PARTICIPANTS, & MEASURES: An observational matched cohort analysis among 40,132 Medicare beneficiaries receiving hemodialysis with a fistula or graft was performed. Cox regression was used to determine whether access intervention was associated with improved 1-year access survival.
RESULTS: Nonsurgical access intervention was found to be frequent at a rate of 20.9 procedures per 100 access years. In the 1-year period after intervention using angiography and PTA, the overall access failure rate was 53.7 per 100 access years in the intervention group and 49.6 in the nonintervention group (HR = 1.02; 95% CI, 0.96 to 1.08). Similar findings were also seen when the analysis was repeated in only fistulas (HR = 1.06; 95% CI, 0.98 to 1.15) and grafts (HR = 0.95; 95% CI, 0.86 to 1.05). In patients with a low intra-access flow rate (HR = 0.86; 95% CI, 0.75 to 0.99) or a new access (HR = 0.79; 95% CI, 0.71 to 0.89), angiography and PTA significantly increased access survival when compared with nonintervention (P for interaction was <0.0001). Angiography-PTA-related upper-extremity hematoma, vessel injury, or embolism-thrombosis occurred in 1.1% of all patients.
CONCLUSIONS: Access characteristics significantly modify the survival benefits of angiography and PTA intervention where the benefits of these interventions are most seen in newer accesses or accesses with insufficient flow.

Entities:  

Mesh:

Year:  2011        PMID: 21959600      PMCID: PMC3359572          DOI: 10.2215/CJN.02860311

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials.

Authors:  A B Parker; C D Naylor
Journal:  Am Heart J       Date:  2000-06       Impact factor: 4.749

2.  Clinical practice guidelines for vascular access.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

3.  Vascular access blood flow monitoring reduces access morbidity and costs.

Authors:  P McCarley; R L Wingard; Y Shyr; W Pettus; R M Hakim; T A Ikizler
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

4.  Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival.

Authors:  Louise M Moist; David N Churchill; Andrew A House; Steven F Millward; James E Elliott; Stewart W Kribs; William J DeYoung; Lesley Blythe; Lawrence W Stitt; Robert M Lindsay
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

5.  A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts.

Authors:  Sunanda J Ram; Jack Work; Gloria C Caldito; J Mark Eason; Aslam Pervez; William D Paulson
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

6.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

Authors:  Ming Teng; Myles Wolf; Edmund Lowrie; Norma Ofsthun; J Michael Lazarus; Ravi Thadhani
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

7.  A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival.

Authors:  Nicola Tessitore; Giancarlo Mansueto; Valeria Bedogna; Giovanni Lipari; Albino Poli; Linda Gammaro; Elda Baggio; Giovanni Morana; Carmelo Loschiavo; Alessandro Laudon; Lamberto Oldrizzi; Giuseppe Maschio
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

8.  Risk of hemodialysis graft thrombosis: analysis of monthly flow surveillance.

Authors:  Sunanda J Ram; Raja Nassar; Jack Work; Kenneth Abreo; Neville R Dossabhoy; William D Paulson
Journal:  Am J Kidney Dis       Date:  2008-10-08       Impact factor: 8.860

9.  Vitamin D levels and early mortality among incident hemodialysis patients.

Authors:  M Wolf; A Shah; O Gutierrez; E Ankers; M Monroy; H Tamez; D Steele; Y Chang; C A Camargo; M Tonelli; R Thadhani
Journal:  Kidney Int       Date:  2007-08-08       Impact factor: 10.612

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

View more
  4 in total

1.  Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.

Authors:  Frank X Liu; Surrey M Walton; Robert Leipold; Deborah Isbell; Thomas A Golper
Journal:  Perit Dial Int       Date:  2014-10-07       Impact factor: 1.756

2.  Dialysis: Early pre-emptive intervention might reduce AVF access loss.

Authors:  Jan H M Tordoir
Journal:  Nat Rev Nephrol       Date:  2013-12-03       Impact factor: 28.314

3.  Development and validation of a risk score to prioritize patients for evaluation of access stenosis.

Authors:  Brad C Astor; Kim Hirschman; John Kennedy; Stan Frinak; Anatole Besarab
Journal:  Semin Dial       Date:  2021-10-12       Impact factor: 2.886

4.  Weight-Based Assessment of Access Flow Threshold to Predict Arteriovenous Fistula Functional Patency.

Authors:  Chih-Yu Yang; Bo-Sheng Wu; Yi-Fang Wang; Yan-Hwa Wu Lee; Der-Cherng Tarng
Journal:  Kidney Int Rep       Date:  2021-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.